Estxone SB 250mg/125mg Injection
Marketer
Ester Formulations
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Estxone SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration requires strict adherence to a healthcare provider's guidance; missed doses should be avoided. Complete the prescribed regimen, even with symptom improvement, as premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are vital for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Estxone SB 250mg/125mg Injection
The provided text is "undefined," offering no content to rephrase.
Uses of Estxone SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Estxone SB 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Estxone SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Estxone SB 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Estxone SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Estxone SB 250mg/125mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Estxone SB 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Estxone SB 250mg/125mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Estxone SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Estxone SB 250mg/125mg Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Estxone SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Estxone SB 250mg/125mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Estxone SB 250mg/125mg Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Estxone SB 250mg/125mg Injection :
Should you forget a scheduled Estxone SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Estxone SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently